
|

| |
Track this member and follow
their portfolio moves with tickerspy™ alerts |
 |
|
donbb
Portfolio List (2): |
Pharm
|
| |
Performance |
|
|
|
Ideas |
|
|
|
Community |
|
| |
Today:
Week:
1-month:
All-time:
|
0.0%
-6.5%
+17.2%
+83.9%
|
vs S&P 500:
vs S&P 500:
vs S&P 500:
vs S&P 500:
|
+0.7%
-6.4%
+11.0%
+57.0%
|
|
|
|
|
|
|
|
|
Share this portfolio on Facebook
Share this portfolio on Twitter
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
| |
|
| |

Click
a column to sort | Scroll over columns for more information |
|
|
| ALXN |
$100.57 |
-2.10 |
-2.0% |
1,131,564 |
71% |
$20.0B |
- |
23% |
-16% |
+30.6% |
new: Alexion Pharmaceuticals, Inc. (Alexion) is a biopharmaceutical company engaged in the discovery, development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in
edited 01/18/12
No Alerts/News
|
|
|
| REGN |
$262.42 |
+2.46 |
+0.9% |
1,060,364 |
65% |
$25.4B |
- |
145% |
-8% |
+232.5% |
new: Regeneron Pharmaceuticals, Inc. (Regeneron) is a biopharmaceutical company. Regeneron discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. As of December 31, 2010, the Company had one market
added 01/18/12
2 Alerts (1 News) - View
|
|
|
|
|
Discuss this portfolio with donbb
|
|
|
|
| |

|
| |
|
| |

|
| |
Dupilumab, a New Drug, May Help Some Asthmatics REGN SNY
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - May 21, 04:12PM from (www.nytimes.com) The number of asthma attacks or other outbreaks of symptoms decreased by 87 percent in those getting the drug, Dupilumab,
Flag
Post a comment
Top New Biotech Ideas from PropThink CELG REGN CBST VPHM ONXX AVEO MAKO
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 16, 07:30AM from (247wallst.com) The world of biotech investing is always a difficult one. Often a binary event, such as a Food and Drug Administration (FDA)
Flag
Post a comment
Deutsche Bank Firm on Biotech Stocks to Buy AMGN CELG REGN BIIB VRTX GILD ALXN ONXX DB
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 15, 08:10AM from (247wallst.com) Biotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and
Flag
Post a comment
Midcaps Double S&P 500 Return: Get the Right ETF XOM FRT GE KSU AAPL O WRI REGN VRTX MDY BRE VO IJH
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - May 07, 09:00AM from (ycharts.com) Granted, Regeneron Pharmaceutical (REGN) Kansas City Southern (KSU) and Vertex Pharmaceuticals (VRTX), the three largest
Flag
Post a comment
Market Wrap for Friday, May 3: Stocks Jump on Strong Jobs Data CAT SCHW REGN GILD SPY ARNA SCOR PKT UUP LNKD KRFT TLT
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 03, 04:28PM from (www.benzinga.com) The U.S. stock market jumped on Friday to end the trading week. The catalyst for the move higher was a strong jobs report,
Flag
Post a comment
Regeneron First-Quarter Profit Tops Estimates on Eylea REGN
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 03, 10:11AM from (www.bloomberg.com) Regeneron Pharmaceuticals Inc. (REGN), maker of the eye medicine Eylea, reported first-quarter profit that topped analysts’
Flag
Post a comment
Top Wall Street Analyst Upgrades: Allergan, Arch, Petrobras and More AGN REGN SPN PVTB IVZ CNH ACI STX REGI LOCK PBR
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 02, 08:40AM from (247wallst.com) Investors and traders are always looking to find fresh research ideas that will lead to higher income or more profits. 24/7
Flag
Post a comment
Regeneron Pharmaceuticals: The Stock That Only Goes Up? AGN REGN SNY
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 01, 04:42PM from (www.benzinga.com) Shares of Regeneron Pharmaceuticals (NASDAQ: REGN) were trading at new all-time high levels on Wednesday afternoon on concerns
Flag
Post a comment
Market Wrap for Wednesday, May 1: Stocks Fall as Employment Data Weakens in April AMD AGN REGN SPY ULTI XXIA MWA UUP SWI RATE TLT
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 01, 04:16PM from (www.benzinga.com) The U.S. stock market was hit hard on Wednesday as investors reacted to a report which showed slowing employment conditions for the month of April.
Flag
Post a comment
Short Sellers Move into Celgene, Regeneron BMY JNJ MRK AMGN CELG REGN BIIB VRTX VVUS GILD ALXN PCYC ONXX ARNA DNDN ILMN NVS
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - April 26, 01:25PM from (www.benzinga.com) The short interest moves in biotech and emerging pharmaceutical companies were mixed in the first two weeks of April.
Flag
Post a comment
Alexion Reports First Quarter 2013 Results ALXN
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - April 25, 06:30AM from (www.businesswire.com) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced financial results and a development pipeline update for the
Flag
Post a comment
Alexion Broadens and Strengthens its Executive Leadership Team ALXN
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - April 25, 06:15AM from (www.businesswire.com) Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that it is broadening and strengthening its executive leadership
Flag
Post a comment
Regeneron Pharmaceuticals to Replace MetroPCS in S&P 500 Index REGN
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - April 24, 05:52PM from (www.bloomberg.com) Regeneron Pharmaceuticals Inc. (REGN), maker of the Eylea eye medicine, will replace MetroPCS Communications Inc. in the
Flag
Post a comment
Alexion Pharmaceuticals to Report First Quarter 2013 Results on Thursday, April 25, 2013 ALXN
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - April 11, 10:00AM from (www.businesswire.com) Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the Company will report its financial results for the first
Flag
Post a comment
UBS Top Picks for Second Quarter for 25 Percent Gains DAL HAL ROST C WFM MNST ALXN ACI TIBX UBS NCT KRA WCRX CIE BLOX
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - April 02, 08:15AM from (247wallst.com) When we started off 2013, most of the Wall St. firms we follow put out their top stock picks for the year. We covered those
Flag
Post a comment
Plant Making Alexion’s $400,000-a-Year Anemia Drug Dinged by FDA Over Contamination Issues ALXN
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - March 28, 05:14PM from (ycharts.com) One of the darlings of the biotech industry has suffered a blow following an FDA inspection of its Rhode Island facility.
Flag
Post a comment
|
|